Presentation of the attention-grabbing case of a affected person affected by castrate-resistant prostate most cancers (CRPC) with bone metastasis, who obtained concomitant treatment with abiraterone acetate (AA) and radium-223. The affected person skilled important scientific enchancment in his high quality of life and ache aid after starting the aforementioned treatment, with out being affected by opposed toxicities.
Currently, the appropriate choice of sufferers to obtain radium-223 treatment remains to be a scientific problem in the case of CRPC with metastasis. In this text, we talk about the future prospects of this treatment, reviewing present evidence about concomitant therapies with radium-223 and its current state, primarily based upon the current suggestions from the Pharmacovigilance Risk Assessment Committee (PRAC), and the knowledge offered in the ERA-223 examine.
Based on our scientific expertise, we offer sensible orientation for the integration of this radiopharmaceutical in the therapeutic plan for this group of sufferers. We conclude, regardless of some of the constructive outcomes and our wonderful expertise, that it will be clever to attend for the outcomes of the scientific trials which are finding out the security and advantages of the combined use of radium-223 with new hormone therapies.
Bearing in thoughts that to this point, the solely revealed large-scale randomised trial that investigated the mixture of AR-axis-targeted remedy with Ra-223 is unfavourable, the harms of the mixture outweighed any advantages in ERA-223. Nonetheless, with a purpose to advocate whether or not or not this treatment must be used, it’s important to outline the affected person profile that would profit from this therapeutic possibility.
Use and affect of the prehospital 12-lead ECG in the main PCI period (PHECG2): protocol for a mixed-method examine.
Use of the prehospital 12-lead ECG (PHECG) is really useful in sufferers presenting to emergency medical providers (EMS) with suspected acute coronary syndrome (ACS).
Prior analysis discovered that though PHECG use was related with improved 30-day survival, a 3rd of sufferers (usually girls, the aged and these with comorbidities) beneath EMS care didn’t obtain a PHECG.The general intention of the PHECG2 examine is to replace evidence on care and outcomes for sufferers eligible for PHECG, particularly addressing the following analysis questions: (1) Is there a distinction in 30-day mortality, and in reperfusion price, between those that do and those that don’t obtain PHECG? (2) Has the proportion of eligible sufferers who obtain PHECG modified since the introduction of main percutaneous coronary intervention networks? (3) Are sufferers that obtain PHECG totally different from these that don’t in phrases of social and demographic elements, or prehospital scientific presentation? (4) What elements affect EMS clinicians’ selections to carry out PHECG?This is an explanatory, mixed-method examine comprising 4 work packages (WPs). WP1 is a population-based, linked-data evaluation of a nationwide ACS registry (Myocardial Ischaemia National Audit Project). WP2 is a retrospective chart overview of affected person information from three giant regional EMS. WP3 contains focus teams of EMS personnel.
NOD1 Antibody |
|||
| 1-CSB-PA876477 | Cusabio |
|
|
|
Description: A polyclonal antibody against NOD1. Recognizes NOD1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:50-1:200 |
|||
NOD1 Antibody |
|||
| CSB-PA015914KA01HU- | Cusabio | 402 EUR | |
|
Description: A polyclonal antibody against NOD1. Recognizes NOD1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200 |
|||
NOD1 Antibody |
|||
| CSB-PA015914KA01HU-100ul | Cusabio | 100ul | 466.8 EUR |
|
Description: A polyclonal antibody against NOD1. Recognizes NOD1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200 |
|||
NOD1 Antibody |
|||
| 32256-100ul | SAB | 100ul | 302.4 EUR |
NOD1 Antibody |
|||
| 5947-002mg | ProSci | 0.02 mg | 206.18 EUR |
|
Description: NOD1 Antibody: NOD1 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD1 contains an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and ten tandem leucine-rich repeats (LRRs) in its C-terminus. The CARD is involved in apoptotic signaling, and NOD1 activates caspase-9 and NF-κB. LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. This protein is an intracellular pattern-recognition receptor (PRR) that initiates inflammation in response to a subset of bacteria through the detection of bacterial diaminopimelic acid. |
|||
NOD1 Antibody |
|||
| 5947-01mg | ProSci | 0.1 mg | 523.7 EUR |
|
Description: NOD1 Antibody: NOD1 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD1 contains an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and ten tandem leucine-rich repeats (LRRs) in its C-terminus. The CARD is involved in apoptotic signaling, and NOD1 activates caspase-9 and NF-κB. LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. This protein is an intracellular pattern-recognition receptor (PRR) that initiates inflammation in response to a subset of bacteria through the detection of bacterial diaminopimelic acid. |
|||
NOD1 Peptide |
|||
| 5947P | ProSci | 0.05 mg | 197.7 EUR |
|
Description: (CT) NOD1 peptide |
|||
NOD1 antibody |
|||
| 70R-13231 | Fitzgerald | 100 ul | 548.4 EUR |
|
Description: Affinity purified Rabbit polyclonal NOD1 antibody |
|||
NOD1 Peptide |
|||
| 42-460P | ProSci | 0.1 mg | 405.6 EUR |
|
Description: (CT) NOD1 Peptide |
|||
Nod1 antibody |
|||
| 22788-100ul | SAB | 100ul | 468 EUR |
NOD1 Antibody |
|||
| 25174-100ul | SAB | 100ul | 468 EUR |
NOD1 Antibody |
|||
| ABD6378 | Lifescience Market | 100 ug | 525.6 EUR |
NOD1 Antibody |
|||
| F54615-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
NOD1 Antibody |
|||
| F54615-0.4ML | NSJ Bioreagents | 0.4 ml | 379 EUR |
Nod1 Antibody |
|||
| R31707 | NSJ Bioreagents | 100 ug | 419 EUR |
NOD1 Antibody |
|||
| R33706-100UG | NSJ Bioreagents | 100 ug | 399 EUR |
NOD1 Antibody |
|||
| RQ5831 | NSJ Bioreagents | 100 ug | 419 EUR |
NOD1 Antibody |
|||
| RQ6083 | NSJ Bioreagents | 100 ug | 419 EUR |
|
Description: Nucleotide-binding oligomerization domain-containing protein 1, also known as CARD4, is a protein receptor that in humans is encoded by the NOD1 gene. NOD1 is a member of NOD-like receptor protein family and is a close relative of NOD2. NOD1 is mapped to 7p14.3. It recognizes bacterial molecules and stimulates an immune reaction. NOD1 protein contains a caspase recruitment domain (CARD). This gene is an intracellular pattern recognition receptor, which is similar in structure to resistant proteins of plants, and mediates innate and acquired immunity by recognizing bacterial molecules containing D-glutamyl-meso-diaminopimelic acid (iE-DAP) moiety. What wore, it has been shown that NOD1 can sense cytosolic microbial products by monitoring the activation state of small Rho GTPases. |
|||
NOD1 cloning plasmid |
|||
| CSB-CL896866HU-10ug | Cusabio | 10ug | 279.6 EUR |
|
Description: A cloning plasmid for the NOD1 gene. |
|||
NOD1 Blocking Peptide |
|||
| DF6378-BP | Affbiotech | 1mg | 234 EUR |
NOD1 Conjugated Antibody |
|||
| C32256 | SAB | 100ul | 476.4 EUR |
NOD1 Rabbit pAb |
|||
| A1246-100ul | Abclonal | 100 ul | 369.6 EUR |
NOD1 Rabbit pAb |
|||
| A1246-200ul | Abclonal | 200 ul | 550.8 EUR |
NOD1 Rabbit pAb |
|||
| A1246-20ul | Abclonal | 20 ul | 219.6 EUR |
NOD1 Rabbit pAb |
|||
| A1246-50ul | Abclonal | 50 ul | 267.6 EUR |
Mouse Nod1 Antibody |
|||
| abx030859-400ul | Abbexa | 400 ul | 627.6 EUR |
Mouse Nod1 Antibody |
|||
| abx030859-80l | Abbexa | 80 µl | 343.2 EUR |
Polyclonal NOD1 Antibody |
|||
| APR06661G | Leading Biology | 0.1 mg | 790.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD1 . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal NOD1 Antibody |
|||
| APR03070G | Leading Biology | 0.05ml | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD1 . This antibody is tested and proven to work in the following applications: |
|||
pCMV-SPORT6-NOD1 |
|||
| PVT14153 | Lifescience Market | 2 ug | 594 EUR |
Anti-NOD1 antibody |
|||
| STJ24778 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene encodes a member of the NOD (nucleotide-binding oligomerization domain) family. This member is a cytosolic protein. It contains an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and 10 tandem leucine-rich repeats (LRRs) in its C terminus. The CARD is involved in apoptotic signaling, LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. This protein is an intracellular pattern-recognition receptor (PRR) that initiates inflammation in response to a subset of bacteria through the detection of bacterial diaminopimelic acid. Multiple alternatively spliced transcript variants differring in the 5' UTR have been described, but the full-length nature of these variants has not been determined. |
|||
Mouse NOD1 shRNA Plasmid |
|||
| 20-abx979820 | Abbexa |
|
|
Human NOD1 shRNA Plasmid |
|||
| 20-abx957041 | Abbexa |
|
|
Human NOD1 ELISA KIT |
|||
| ELI-46124h | Lifescience Market | 96 Tests | 988.8 EUR |
Mouse Nod1 ELISA KIT |
|||
| ELI-35306m | Lifescience Market | 96 Tests | 1038 EUR |
NOD1 ELISA KIT|Human |
|||
| EF005372 | Lifescience Market | 96 Tests | 826.8 EUR |
Anti-CARD4/NOD1 Antibody |
|||
| PB9294 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-NOD1 / CARD4 antibody |
|||
| STJ70152 | St John's Laboratory | 100 µg | 430.8 EUR |
Polyclonal NOD1 Antibody (C-Terminus) |
|||
| APR02775G | Leading Biology | 0.05mg | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD1 (C-Terminus). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal NOD1 Antibody (aa930-949) |
|||
| APR02826G | Leading Biology | 0.05ml | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD1 (aa930-949). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal NOD1 Antibody (C-term) |
|||
| APR03618G | Leading Biology | 0.1ml | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD1 (C-term). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal Mouse Nod1 Antibody (Center) |
|||
| APR04406G | Leading Biology | 0.1ml | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Mouse Nod1 (Center). This antibody is tested and proven to work in the following applications: |
|||
NOD1 ELISA Kit (Human) (OKCA00743) |
|||
| OKCA00743 | Aviva Systems Biology | 96 Wells | 999.6 EUR |
|
Description: Description of target: Enhances caspase-9-mediated apoptosis. Induces NF-kappa-B activity via RIPK2 and IKK-gamma. Confers responsiveness to intracellular bacterial lipopolysaccharides (LPS). Forms an intracellular sensing system along with ARHGEF2 for the detection of microbial effectors during cell invasion by pathogens. Required for RHOA and RIPK2 dependent NF-kappa-B signaling pathway activation upon S.flexneri cell invasion. Involved not only in sensing peptidoglycan (PGN)-derived muropeptides but also in the activation of NF-kappa-B by Shigella effector proteins IpgB2 and OspB. Recruits NLRP10 to the cell membrane following bacterial infection.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 3.9 pg/mL |
|||
Nod1 ORF Vector (Rat) (pORF) |
|||
| ORF071394 | ABM | 1.0 ug DNA | 607.2 EUR |
NOD1 ELISA Kit (Human) (OKEH08039) |
|||
| OKEH08039 | Aviva Systems Biology | 96 Wells | 1075.2 EUR |
|
Description: Description of target: This gene encodes a member of the nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) family of proteins. The encoded protein plays a role in innate immunity by acting as a pattern-recognition receptor (PRR) that binds bacterial peptidoglycans and initiates inflammation. This protein has also been implicated in the immune response to viral and parasitic infection. Major structural features of this protein include an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and 10 tandem leucine-rich repeats (LRRs) in its C terminus. The CARD is involved in apoptotic signaling, LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. Mutations in this gene are associated with asthma, inflammatory bowel disease, Behcet disease and sarcoidosis in human patients.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.078 ng/mL |
|||
NOD1 ELISA Kit (Mouse) (OKEH08040) |
|||
| OKEH08040 | Aviva Systems Biology | 96 Wells | 1310.4 EUR |
|
Description: Description of target: ;Species reactivity: Mouse;Application: ELISA;Assay info: Assay Methodology: Quantitative Competitive ELISA;Sensitivity: 0.096ng/mL |
|||
NOD1 ORF Vector (Human) (pORF) |
|||
| ORF007140 | ABM | 1.0 ug DNA | 114 EUR |
Nod1 ORF Vector (Mouse) (pORF) |
|||
| ORF051497 | ABM | 1.0 ug DNA | 607.2 EUR |
Nod1 ORF Vector (Mouse) (pORF) |
|||
| ORF051498 | ABM | 1.0 ug DNA | 607.2 EUR |
h NOD1 inducible lentiviral particles |
|||
| LVP751 | GenTarget | 1x107 IFU/ml x 200ul | 541.2 EUR |
|
Description: Pre-made over-expression lentivirus for expressing human target: h NOD1 (nucleotide-binding oligomerization domain containing 1), [alternative names: CARD4; CLR7.1; NLRC1]. The sub-cloned codon sequence is identical (100% match) to CDS region in NCBI ID: NM_006092. It also contains a RFP-Blasticidin dual selection marker. |
|||
Polyclonal NOD1 / CARD4 Antibody (C-Term) |
|||
| APG00381G | Leading Biology | 0.1mg | 580.8 EUR |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human NOD1 / CARD4 (C-Term). This antibody is tested and proven to work in the following applications: |
|||
NOD1 sgRNA CRISPR Lentivector set (Human) |
|||
| K1438501 | ABM | 3 x 1.0 ug | 406.8 EUR |
Nod1 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K3911101 | ABM | 3 x 1.0 ug | 406.8 EUR |
Nod1 sgRNA CRISPR Lentivector set (Rat) |
|||
| K6741701 | ABM | 3 x 1.0 ug | 406.8 EUR |
NOD1 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K1438502 | ABM | 1.0 ug DNA | 184.8 EUR |
NOD1 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K1438503 | ABM | 1.0 ug DNA | 184.8 EUR |
NOD1 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K1438504 | ABM | 1.0 ug DNA | 184.8 EUR |
Nod1 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
| K3911102 | ABM | 1.0 ug DNA | 184.8 EUR |
Nod1 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
| K3911103 | ABM | 1.0 ug DNA | 184.8 EUR |
Nod1 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
| K3911104 | ABM | 1.0 ug DNA | 184.8 EUR |
Nod1 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
| K6741702 | ABM | 1.0 ug DNA | 184.8 EUR |
Nod1 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
| K6741703 | ABM | 1.0 ug DNA | 184.8 EUR |
Nod1 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
| K6741704 | ABM | 1.0 ug DNA | 184.8 EUR |
NOD1 Protein Vector (Human) (pPB-C-His) |
|||
| PV028557 | ABM | 500 ng | 394.8 EUR |
NOD1 Protein Vector (Human) (pPB-N-His) |
|||
| PV028558 | ABM | 500 ng | 394.8 EUR |
NOD1 Protein Vector (Human) (pPM-C-HA) |
|||
| PV028559 | ABM | 500 ng | 394.8 EUR |
NOD1 Protein Vector (Human) (pPM-C-His) |
|||
| PV028560 | ABM | 500 ng | 394.8 EUR |
NOD1 Protein Vector (Rat) (pPB-C-His) |
|||
| PV285574 | ABM | 500 ng | 1429.2 EUR |
NOD1 Protein Vector (Rat) (pPB-N-His) |
|||
| PV285575 | ABM | 500 ng | 1429.2 EUR |
NOD1 Protein Vector (Rat) (pPM-C-HA) |
|||
| PV285576 | ABM | 500 ng | 1429.2 EUR |
NOD1 Protein Vector (Rat) (pPM-C-His) |
|||
| PV285577 | ABM | 500 ng | 1429.2 EUR |
NOD1 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV205986 | ABM | 500 ng | 1278 EUR |
NOD1 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV205987 | ABM | 500 ng | 1278 EUR |
NOD1 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV205988 | ABM | 500 ng | 1278 EUR |
NOD1 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV205989 | ABM | 500 ng | 1278 EUR |
NOD1 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV205990 | ABM | 500 ng | 1278 EUR |
NOD1 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV205991 | ABM | 500 ng | 1278 EUR |
NOD1 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV205992 | ABM | 500 ng | 1278 EUR |
NOD1 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV205993 | ABM | 500 ng | 1278 EUR |
Nod1 3'UTR Luciferase Stable Cell Line |
|||
| TU214064 | ABM | 1.0 ml | Ask for price |
Nod1 3'UTR GFP Stable Cell Line |
|||
| TU264064 | ABM | 1.0 ml | Ask for price |
Nod1 3'UTR Luciferase Stable Cell Line |
|||
| TU114190 | ABM | 1.0 ml | Ask for price |
Nod1 3'UTR GFP Stable Cell Line |
|||
| TU164190 | ABM | 1.0 ml | Ask for price |
NOD1 3'UTR GFP Stable Cell Line |
|||
| TU065800 | ABM | 1.0 ml | 1825.2 EUR |
NOD1 3'UTR Luciferase Stable Cell Line |
|||
| TU015800 | ABM | 1.0 ml | 1825.2 EUR |
NOD1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
| LV645613 | ABM | 1.0 ug DNA | 1626 EUR |
NOD1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV645617 | ABM | 1.0 ug DNA | 1626 EUR |
NOD1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV645618 | ABM | 1.0 ug DNA | 1626 EUR |
Nod1 ELISA Kit| Mouse Nucleotide-binding oligomerization domain |
|||
| EF015735 | Lifescience Market | 96 Tests | 826.8 EUR |
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Antibody |
|||
| 20-abx104722 | Abbexa |
|
|
Nucleotide-Binding Oligomerization Domain-Containing Protein 1 (NOD1) Antibody |
|||
| abx117079-100ug | Abbexa | 100 ug | 560.4 EUR |
Nucleotide-Binding Oligomerization Domain-Containing Protein 1 (NOD1) Antibody |
|||
| 20-abx001158 | Abbexa |
|
|
Nucleotide-Binding Oligomerization Domain-Containing Protein 1 (NOD1) Antibody |
|||
| abx038077-100ug | Abbexa | 100 ug | 469.2 EUR |
Nucleotide-Binding Oligomerization Domain-Containing Protein 1 (NOD1) Antibody |
|||
| abx026454-400ul | Abbexa | 400 ul | 627.6 EUR |
Nucleotide-Binding Oligomerization Domain-Containing Protein 1 (NOD1) Antibody |
|||
| abx026454-80l | Abbexa | 80 µl | 343.2 EUR |
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Antibody |
|||
| 20-abx212259 | Abbexa |
|
|
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Antibody |
|||
| 20-abx212260 | Abbexa |
|
|
Nucleotide-Binding Oligomerization Domain-Containing Protein 1 (NOD1) Antibody |
|||
| abx430272-200ul | Abbexa | 200 ul | 460.8 EUR |
Recombinant Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) |
|||
| 4-RPK296Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Nucleotide Binding Oligomerization Domain Containing Protein 1 expressed in: E.coli |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Protein |
|||
| 20-abx068373 | Abbexa |
|
|
NOD1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K1438505 | ABM | 3 x 1.0 ug | 451.2 EUR |
Nod1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
| K3911105 | ABM | 3 x 1.0 ug | 451.2 EUR |
Nod1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
| K6741705 | ABM | 3 x 1.0 ug | 451.2 EUR |
Human Nucleotide-binding oligomerization domain-containing protein 1(NOD1) ELISA kit |
|||
| CSB-EL015914HU-24T | Cusabio | 1 plate of 24 wells | 198 EUR |
|
Description: Quantitativesandwich ELISA kit for measuring Human Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) in samples from serum, plasma, tissue homogenates, cell lysates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Human Nucleotide-binding oligomerization domain-containing protein 1(NOD1) ELISA kit |
|||
| 1-CSB-EL015914HU | Cusabio |
|
|
|
Description: Quantitativesandwich ELISA kit for measuring Human Nucleotide-binding oligomerization domain-containing protein 1(NOD1) in samples from serum, plasma, tissue homogenates, cell lysates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
Mouse Nod1/ Nucleotide-binding oligomerization domain-containing protein 1 ELISA Kit |
|||
| E1036Mo | Sunlong | 1 Kit | 758.4 EUR |
Mouse Nucleotide-Binding Oligomerization Domain-Containing Protein 1 (NOD1) ELISA Kit |
|||
| abx555520-96tests | Abbexa | 96 tests | 886.8 EUR |
Human Nucleotide-Binding Oligomerization Domain-Containing Protein 1 (NOD1) ELISA Kit |
|||
| abx556317-96tests | Abbexa | 96 tests | 801.6 EUR |
NOD1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
| LV645614 | ABM | 1.0 ug DNA | 1626 EUR |
NOD1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
| LV645615 | ABM | 1.0 ug DNA | 1695.6 EUR |
NOD1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
| LV645616 | ABM | 1.0 ug DNA | 1695.6 EUR |
Human Nod1 (Apaf-1 like protein/CARD4) Control/blocking peptide #1 |
|||
| NOD11-P | Alpha Diagnostics | 100 ug | 196.8 EUR |
Rabbit Anti-Human Nod1 (Apaf-1 like protein/CARD4) antiserum #1 |
|||
| NOD11-S | Alpha Diagnostics | 100 ul | 548.4 EUR |
NOD1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
| K1438506 | ABM | 1.0 ug DNA | 200.4 EUR |
NOD1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
| K1438507 | ABM | 1.0 ug DNA | 200.4 EUR |
NOD1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
| K1438508 | ABM | 1.0 ug DNA | 200.4 EUR |
Nod1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
| K3911106 | ABM | 1.0 ug DNA | 200.4 EUR |
Nod1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
| K3911107 | ABM | 1.0 ug DNA | 200.4 EUR |
Nod1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
| K3911108 | ABM | 1.0 ug DNA | 200.4 EUR |
Nod1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
| K6741706 | ABM | 1.0 ug DNA | 200.4 EUR |
Nod1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
| K6741707 | ABM | 1.0 ug DNA | 200.4 EUR |
Nod1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
| K6741708 | ABM | 1.0 ug DNA | 200.4 EUR |
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Polyclonal Antibody (Human) |
|||
| 4-PAK296Hu01 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) |
|||
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Polyclonal Antibody (Human), APC |
|||
| 4-PAK296Hu01-APC | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1). This antibody is labeled with APC. |
|||
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Polyclonal Antibody (Human), Biotinylated |
|||
| 4-PAK296Hu01-Biotin | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1). This antibody is labeled with Biotin. |
|||
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Polyclonal Antibody (Human), Cy3 |
|||
| 4-PAK296Hu01-Cy3 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1). This antibody is labeled with Cy3. |
|||
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Polyclonal Antibody (Human), FITC |
|||
| 4-PAK296Hu01-FITC | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1). This antibody is labeled with FITC. |
|||
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Polyclonal Antibody (Human), HRP |
|||
| 4-PAK296Hu01-HRP | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1). This antibody is labeled with HRP. |
|||
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Polyclonal Antibody (Human), PE |
|||
| 4-PAK296Hu01-PE | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1). This antibody is labeled with PE. |
|||
Rabbit Anti-Human Nod1 (Apaf-1 like protein/CARD4) IgG #1, aff pure |
|||
| NOD11-A | Alpha Diagnostics | 100 ug | 578.4 EUR |
Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1) Polyclonal Antibody (Human), APC-Cy7 |
|||
| 4-PAK296Hu01-APC-Cy7 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Nucleotide Binding Oligomerization Domain Containing Protein 1 (NOD1). This antibody is labeled with APC-Cy7. |
|||
WP4 will synthesise findings from WP1-Three to tell the growth of an intervention to extend PHECG uptake.The examine has been accepted by the London-Hampstead Research Ethics Committee (ref: 18LO1679). Findings shall be disseminated via suggestions to collaborating EMS, convention displays and publication in peer-reviewed journals.NCT03699137.